SearchDictionaryMobileLogin

Blue Nevus

75  relevant articles (1 outcomes, 5 trials/studies) found for this Disease

Description: Usually a benign tumor, that commonly presents as a solitary blue nodule with spindled MELANOCYTES covered by smooth SKIN. Several variants have been identified, one variant being malignant. The blue color is caused by large, densely packed melanocytes deep in the DERMIS of the nevus. In CHILDREN, they usually occur on the BUTTOCKS and LUMBOSACRAL REGION and are referred to as cellular blue nevi. Malignant blue nevi are more commonly found on the SCALP.

Also Known As:
Nevus, Blue; Blue Nevi; Blue Nevus, Cellular; Cellular Blue Nevi; Blue Nevi, Cellular; Nevi, Blue; Nevi, Cellular Blue; Nevus, Cellular Blue; Cellular Blue Nevus

Relationship Network

Disease Context: Research Results

Related Diseases

1. Seborrheic Keratosis
2. Fibrosis (Cirrhosis)
3. Cysts
4. Telangiectasis (Telangiectasia)
5. Melanoma (Melanoma, Malignant)

Experts

1. Gasior-Chrzan, B: 1 article (01/2001)
2. Minami, H: 1 article (05/2000)
3. Sakakibara, N: 1 article (05/2000)
4. Sato, K: 1 article (05/2000)
5. Tsuji, T: 1 article (05/2000)
6. Hasegawa, K: 1 article (05/2000)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Blue Nevus:
1. Melanins (Melanin)IBA
2. neodymium pyrocatechin disulfonate (NPD)IBA
3. S100 Proteins (S 100 Protein)IBA
4. ParaffinIBA
03/01/1989 - "The recently described method of staining nucleolar organizer regions (NOR) with colloidal silver nitrate was applied to the paraffin sections of five junctional nevi, 13 compound nevi, seven Spitz nevi, nine cellular blue nevi, 11 dysplastic nevi, seven malignant lentigines, 12 superficial spreading melanomas, and 14 secondary melanomas"
04/01/1996 - "We have investigated immunohistochemically the expression of CD44S and the variant isoforms CD44v3 and CD44v6 in paraffin-embedded tissue from 5 Spitz nevi, 3 compound melanocytic nevi, 2 blue nevi, 6 primary melanomas, 15 cutaneous metastases (three epidermotropic, nine dermal and three ulcerated) and 10 lymph node metastases of melanoma"
08/01/1991 - "Using a silver staining technique, we studied nucleolar organizer regions (AgNOR) in paraffin sections of junctional nevi, compound nevi, intradermal nevi, blue nevi, dysplastic nevi, Spitz nevi, lentigo maligna, malignant melanomas in nevus, superficial spreading melanomas, and nodular melanomas"
04/01/1999 - "Tissue samples of 55 formalin-fixed, paraffin-embedded melanoma (primary n=32, metastatic n=23) and of 27 control cases (junctional dermal, compound, Spitz, Reed, blue nevi, balloon-cell nevus, lentigo maligna) were analyzed by immunohistochemistry with anti-cellular apoptosis susceptibility antibodies"
12/01/1993 - "The proliferative activity of four malignant cellular blue nevi (MCBN) was assessed in routinely fixed, paraffin-embedded material using staining for the argyrophilic nucleolar organizer regions (AgNORs), immunohistochemical staining for proliferating cell nuclear antigen (PCNA [PC10]), and DNA flow cytometry"
Order ALL the reference details at left...
5. tebufenozide (Mimic)IBA
6. 9,10-Dimethyl-1,2-benzanthracene (DMBA)IBA
7. NAD (NADH)IBA
8. CollagenIBA
9. styrene-methylmethacrylate copolymerIBA
10. Proliferating Cell Nuclear Antigen (PCNA)IBA

Therapies and Procedures

1. Semiconductor Lasers
2. Hysterectomy
3. Solid-State Lasers
4. Laser Therapy (Surgery, Laser)
5. Tissue Expansion Devices (Tissue Expander)

Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>